Adamas to Announce First Quarter 2018 Financial Results and Host Conference Call on May 3, 2018
Apr 26, 2018 20:06 pm UTC| Business
EMERYVILLE, Calif., April 26, 2018 -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced that the company will report first quarter 2018 financial results on Thursday, May 3, 2018, after market close....
Apr 26, 2018 20:06 pm UTC| Business
HOUSTON, April 26, 2018 -- Gulf Island Fabrication, Inc. (“Gulf Island” or the “Company”) (NASDAQ:GIFI) announced today that both of its Class III directors, Kirk J. Meche, Gulf Island’s President and Chief Executive...
First Business Reports First Quarter 2018 Financial Results
Apr 26, 2018 20:06 pm UTC| Business
MADISON, Wis., April 26, 2018 -- First Business Financial Services, Inc. (the “Company” or “First Business”) (NASDAQ:FBIZ) reported first quarter 2018 results, which included the highest first quarter loan growth in...
AV Homes Reports Results for First Quarter 2018
Apr 26, 2018 20:06 pm UTC| Business
Reaffirms Full Year 2018 Outlook First Quarter 2018 Highlights - as compared to the prior year first quarter (unless otherwise noted) Net new order value increased 13% to $242.0 million on a 10% increase in unitsBacklog...
DMC Global Reports First Quarter Financial Results
Apr 26, 2018 20:06 pm UTC| Business
First quarter sales of $67.3 million increased 24% sequentially and 73% from Q1 2017DynaEnergetics and NobelClad report sequential sales increases of 32% and 5%, respectivelyConsolidated gross margin improves to 34% from...
Financial Institutions, Inc. Announces First Quarter 2018 Results
Apr 26, 2018 20:06 pm UTC| Business
WARSAW, N.Y., April 26, 2018 -- Financial Institutions, Inc. (Nasdaq:FISI), today reported financial and operational results for the first quarter ended March 31, 2018. Financial Institutions, Inc. (the “Company”) is...
Vital Therapies Announces Upcoming First Quarter Financial Results Conference Call with Webcast
Apr 26, 2018 20:06 pm UTC| Business
SAN DIEGO, April 26, 2018 -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, will release its first quarter...